FDA Initiates Pilot Program to Mitigate Risks in Utilizing Laboratory Developed Tests for Cancer Biomarker Identification
The U.S. Food and Drug Administration (FDA) has launched a new voluntary pilot program aimed at improving the selection of cancer treatments for patients. The program focuses on certain oncology drug products used with corresponding in vitro diagnostic tests. These tests provide essential information for the safe and effective use of specific cancer treatments. The […]